logo
Plus   Neg
Share
Email

Pentair Boosts FY19 Earnings Guidance - Quick Facts

While reporting financial results for the second quarter, Pentair plc (PNR) on Tuesday raised its earnings and adjusted earnings guidance for the full-year 2019, while maintaining sales growth guidance. The company also initiated third-quarter outlook.

For fiscal 2019, the company now projects earnings of about $2.13 per share and adjusted earnings of about $2.35 per share. The company now expects sales to be about flat to up 1 percent on a reported basis and about flat to down 1 percent on a core basis from last year.

The company reiterates its full year 2019 sales guidance of up approximately 1 to 2 percent on a reported basis and approximately flat to up 1 percent on a core basis

Previously, the company expected earnings from continuing operations in a range of about $2.04 to $2.09 per share and on an adjusted basis in the range of about $2.30 to $2.35 per share. It also projected full year 2019 sales to be up about 1 to 2 percent on a reported basis and about flat to up 1 percent on a core basis.

On average, 16 analysts polled by Thomson Reuters expect the company to report earnings of $2.31 per share on sales growth of 1.4 percent to $3.01 billion for the year. Analysts' estimates typically exclude special items.

For the third quarter, the company projects earnings in a range of about $0.50 to $0.52 per share and on an adjusted basis in the range of about $0.54 to $0.56 per share on sales of about flat to up 2 percent on a reported basis and about down 1 to 3 percent on a core basis from last year.

The Street is looking for earnings of $0.57 per share on sales growth of 4.5 percent to $743.26 million for the third quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
J. M. Smucker Co. is recalling certain Natural Balance canned cat food, citing health concerns likely associated with increased levels of choline chloride, an animal growth promotant, the U.S. Food and Drug Administration said in a statement. The recall was initiated after receiving reports of adverse reactions. Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles. Gilead Sciences Inc. (GILD) said Friday that the European Commission has granted conditional marketing authorization for Veklury or remdesivir as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19.
Follow RTT